Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Debt / NOTE 1.875% 4/2
-
Market price (% of par)
-
347.94%
-
Total 13F principal
-
$59,395,000
-
Principal change
-
-$1,230,000
-
Total reported market value
-
$206,328,000
-
Number of holders
-
18
-
Value change
-
-$4,420,000
-
Number of sells
-
2
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.875% 4/2 as of Q4 2013
As of 31 Dec 2013,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.875% 4/2 was held by
18 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$59,395,000
in principal (par value) of the bond.
The largest 10 bondholders included
BAKER BROS. ADVISORS LP, Amici Capital, LLC, ANGELO GORDON & CO., L.P., CITIGROUP INC, DEUTSCHE BANK AG\, FRANKLIN RESOURCES INC, LORD, ABBETT & CO. LLC, RWC Asset Management LLP, Cheyne Capital Management (UK) LLP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
18
institutional bondholders reporting positions
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.